Sage Journals: Discover world-class research

Abstract

This review examines the clinical, morphological, and systemic factors related to coronavirus disease 2019 (COVID-19) cutaneous manifestations. The EMBASE, Medline, and Pubmed Central databases were searched from February 1, 2020 until April 25, 2020, using the search words “(COVID-19 OR SARS-CoV-2 OR coronavirus-19) AND (skin OR cutaneous OR dermatologic)”. Cutaneous manifestations of COVID-19 were included. The cutaneous manifestations can be classified into 2 types. Patients with inflammatory reactions consisted of morbilliform, varicella-like, urticarial eruptions, and vesiculobullous manifestations. These manifestations were mainly found on the trunk, limbs, and faces of patients and had mainly positive COVID-19 polymerase chain reaction findings (97.7%). Furthermore, there were 516 patients with acral vascular lesions: chilblains, livedo lesions, cutaneous small-vessel vasculitis, and other noninflammatory purpura. These were often nonpruritic (88%) and not seen in severe disease (88.7%). The cutaneous lesions have potential for early diagnosis of COVID-19 and prevention of disease transmission. The implications of COVID-19 in the field of dermatology continue to evolve as more clinical data becomes available.

Keywords

COVID-19 cutaneous manifestations cutaneous inflammatory vascular

Get full access to this article

View all access options for this article.

References

Recalcati

. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-e213.doi:10.1111/jdv.16387

http://www.ncbi.nlm.nih.gov/pubmed/32215952

Jin

Y-H.

Cai

Cheng

Z-S

et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.doi:10.1186/s40779-020-0233-6

http://www.ncbi.nlm.nih.gov/pubmed/32029004

Wang

Rademaker

Baker

Foley

. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: an Australian/New Zealand consensus statement. Australas J Dermatol. 2020;61(3):210-216.doi:10.1111/ajd.13313

http://www.ncbi.nlm.nih.gov/pubmed/32255510

Guan

et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382(18):1720. doi:10.1056/NEJMoa2002032

Zhang

Xiao

Zhang

et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575

http://www.ncbi.nlm.nih.gov/pubmed/32268022

Galván Casas

Català

Carretero Hernández

et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77.doi:10.1111/bjd.19163

http://www.ncbi.nlm.nih.gov/pubmed/32348545

Tammaro

Adebanjo

GAR.

Parisella

FR.

Pezzuto

Rello

. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020;34(7):e306-e307.doi:10.1111/jdv.16530

http://www.ncbi.nlm.nih.gov/pubmed/32330340

de Masson

Bouaziz

J-D.

Sulimovic

et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J Am Acad Dermatol. 2020;83(2):667-670.doi:10.1016/j.jaad.2020.04.161

http://www.ncbi.nlm.nih.gov/pubmed/32380219

Bouaziz

JD.

Duong

TA.

Jachiet

et al. Vascular skin symptoms in COVID-19: a French observational study. J Eur Acad Dermatol Venereol. 2020;10.1111/jdv.16544 doi:10.1111/jdv.16544 27 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32339344

10.

Marzano

AV.

Genovese

Fabbrocini

et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-285.doi:10.1016/j.jaad.2020.04.044

http://www.ncbi.nlm.nih.gov/pubmed/32305439

11.

Jimenez-Cauhe

Ortega-Quijano

Prieto-Barrios

Moreno-Arrones

OM.

Fernandez-Nieto

. Reply to “COVID-19 can present with a rash and be mistaken for Dengue”: Petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol. 2020;83(2):e141-e142.doi:10.1016/j.jaad.2020.04.016

http://www.ncbi.nlm.nih.gov/pubmed/32283233

12.

Mahé

Birckel

Krieger

Merklen

Bottlaender

. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246-e247.doi:10.1111/jdv.16471

http://www.ncbi.nlm.nih.gov/pubmed/32294259

13.

Henry

Ackerman

Sancelme

Finon

Esteve

. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(6):e244-e245.doi:10.1111/jdv.16472

http://www.ncbi.nlm.nih.gov/pubmed/32294273

14.

Lin

Zhang

et al. Alert for non‐respiratory symptoms of coronavirus disease 2019 patients in epidemic period: a case report of familial cluster with three asymptomatic COVID‐19 patients. J Med Virol. 2020;41(2):1-4.doi:10.1002/jmv.25776

15.

Fernandez‐Nieto

Ortega‐Quijano

Segurado‐Miravalles

Pindado‐Ortega

Prieto‐Barrios

Jimenez‐Cauhe

. Comment on: cutaneous manifestations in COVID‐19: a first perspective. safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020;34(6).doi:10.1111/jdv.16470

16.

Hunt

Koziatek

. A case of COVID-19 pneumonia in a young male with full body rash as a presenting symptom. Clin Pract Cases Emerg Med. 2020;4(2):219-221.doi:10.5811/cpcem.2020.3.47349

http://www.ncbi.nlm.nih.gov/pubmed/32282312

17.

Ladha

MA.

Luca

Constantinescu

Naert

Ramien

. Approach to chilblains the COVID-19 pandemic. J Cutan Med Surg. 2020;24(5):504-517.doi:10.1177/1203475420937978

18.

Fernandez-Nieto

Jimenez-Cauhe

Suarez-Valle

et al. Comment on “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak”. J Am Acad Dermatol. 2020;83(3):e241. doi:10.1016/j.jaad.2020.05.120

http://www.ncbi.nlm.nih.gov/pubmed/32497704

19.

Kolivras

Dehavay

Delplace

et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep. 2020;6:489-492.doi:10.1016/j.jdcr.2020.04.011

http://www.ncbi.nlm.nih.gov/pubmed/32363225

20.

Garcia-Lara

Linares-González

Ródenas-Herranz

Ruiz-Villaverde

. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak. Dermatol Ther. 2020;e13516. doi:10.1111/dth.13516

http://www.ncbi.nlm.nih.gov/pubmed/32378284

21.

Piccolo

Neri

Filippeschi

et al. Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol. 2020;34(7):1-3.doi:10.1111/jdv.16526

22.

Andina

Noguera-Morel

Bascuas-Arribas

et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020;37(3):406-411.doi:10.1111/pde.14215

http://www.ncbi.nlm.nih.gov/pubmed/32386460

23.

Recalcati

Barbagallo

Frasin

et al. Acral cutaneous lesions in the time of COVID‐19. J Eur Acad Dermatol Venereol. 2020;34(8).doi:10.1111/jdv.16533

24.

Magro

Mulvey

JJ.

Berlin

et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1-13.doi:10.1016/j.trsl.2020.04.007

http://www.ncbi.nlm.nih.gov/pubmed/32299776

25.

Zhuo

Ren

Zhang

. Overly exuberant innate immune response to SARS-CoV-2 infection: request PDF. ResearchGate. Accessed April 24, 2020. https://www.researchgate.net/publication/340171845_Overly_Exuberant_Innate_Immune_Response_to_SARS-CoV-2_Infection

26.

Blanco-Melo

Nilsson-Payant

BE.

Liu

W-C

et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. bioRxiv. 2020.doi:1101/2020.03.24.004655

27.

Zhang

Cao

Xiao

et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020;41(0):E006. doi:10.3760/cma.j.issn.0253-2727.2020.0006

http://www.ncbi.nlm.nih.gov/pubmed/32220276

28.

Hunt

Koziatek

. A case of COVID-19 pneumonia in a young male with full body rash as a presenting symptom. Clin Pract and Cases in Emerg Med. 2020;4(2):219-221.doi:10.5811/cpcem.2020.3.47349

29.

Toubiana

Poirault

Corsia

et al. Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France. medRxiv. April 2020. https://www.medrxiv.org/content/10.1101/2020.05.10.20097394v1

30.

Jones

Mills

Suarez

. COVID-19 and Kawasaki disease: novel virus and novel case. Hospital Pediatrics. 2020;10(6):1-4.

31.

Grant-Kels

JM.

Sloan

Kantor

Elston

. Letter from the editors: big data and cutaneous manifestations of COVID-19. J Am Acad Dermatol. 2020;83(2):263-266.doi:10.1016/j.jaad.2020.04.050

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.01 MB

0.00 MB

Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns

Abstract

Keywords

Get full access to this article

References

Supplementary Material